Luye Pharma Group Ltd (2186.HK) revealed earnings for full year of RMB618.75 million
The company's earnings came in at RMB618.75 million, or RMB0.125 per share. This compares with RMB471.89 million, or RMB0.1254 per share, last year.
The company's revenue for the period rose 4.1% to RMB6.308 billion from RMB6.061 billion last year.
Luye Pharma Group Ltd earnings at a glance (GAAP) :
-Earnings: RMB618.75 Mln. vs. RMB471.89 Mln. last year.-EPS: RMB0.125 vs. RMB0.1254 last year.-Revenue: RMB6.308 Bln vs. RMB6.061 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.